Classification of the Stages of Nonalcoholic Steatohepatitis via Federated General Visual Representation Learningdoi:10.1002/ima.23118Nergiz, MehmetInternational Journal of Imaging Systems & Technology
Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. presentations and discussions at a Single Topic Conference held September 20-22, 2002, and sponsored by the American Association for the Study of Liver ... BA Neuschwander‐Tetri,SH Caldwell - 《Hepatology》 被引量: 3339...
Nonalcoholic steatohepatitis (NASH), as a severe form of nonalcoholic fatty liver disease (NAFLD), is characterized by liver steatosis, inflammation, hepatocellular injury and different degrees of fibrosis. The pathogenesis of NASH is complex and multifactorial, obesity and type 2 diabetes mellitus (T...
Nonalcoholic steatohepatitis (NASH), unlike simple steatosis, is a potentially progressive disease. Various types of drugs have been explored for the treatment of NASH. We reviewed the various therapies available, with particular emphasis on their efficacy for the improvement of hepatic fibrosis. Treatm...
Non-alcoholic fatty liver disease (NAFLD) includes a range of hepatic manifestations, starting with liver steatosis and potentially evolving towards non-alcoholic steatohepatitis (NASH), cirrhosis or even hepatocellular carcinoma. NAFLD is a major health burden, and its incidence is increasing worldwide...
Metabonomics screening of serum identifies pyroglutamate as a diagnostic biomarker for nonalcoholic steatohepatitis. Clin. Chim. Acta 473, 89–95 (2017). Article CAS PubMed Google Scholar Dong, S. et al. Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic ...
Synonyms NASH Definition and Characteristics Nonalcoholic steatohepatitis (NASH) is part of the spectrum of nonalcoholic fatty liver disease (NAFLD). NAFLD encompasses hepatic lesions such as steatosis, steatohepatitis, fibrosis, cirrhosis, and in some cases hepatocellular carcinoma. NASH mimics alcoholic ...
2023年4月9日,安徽医科大学/南京医科大学孙倍成团队在Journal of Hepatology(If=30)在线发表了题为“A TNFα/Miz1-positive feedback loop inhibits mitophagy in hepatocytes and propagates nonalcoholic steatohepatitis”的研究论文,该研究发现在人类NASH中,Miz1的含量在肝细胞中减少。Miz1被证明与过氧化物还蛋白6...
The liver biopsy can confirm the etiology of NASH or alcoholic steatohepatitis (ASH) and assess structural alterations of cells, their organelles, as well as inflammatory activity. Three histological stages of ALD are simple steatosis, ASH, and chronic hepatitis with hepatic fibrosis or cirrhosis. ...
NASH(non-alcoholic steatohepatitis),即非酒精性脂肪性肝炎,是由肝脏中脂肪堆积引起的肝脏疾病和炎症。根据流行病学数据,全球酒精性脂肪肝病(non-alcoholic fatty liver disease,NAFLD)发病率约25%,这些患者约有10-20%的可能进展为NASH,全球各地NASH发病率约为1.5%至6.5%,中国约为3.5%(即目前美国NASH患者人数约为...